Echo Therapeutics, Inc. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ff6ef16c-a978-4cc5-b8d5-7f5310ea7936/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-17.5M | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-005383 |
| FY 2014 | $-12.3M | 2014-01-01 – 2014-12-31 | evidence 0001415889-16-005383 |
| FY 2013 | $-19.6M | 2013-01-01 – 2013-12-31 | evidence 0001415889-15-001364 |
| FY 2012 | $-15.0M | 2012-01-01 – 2012-12-31 | evidence 0001415889-13-000438 |
| FY 2011 | $-8.3M | 2011-01-01 – 2011-12-31 | evidence 0001415889-12-000359 |
| FY 2010 | $-4.9M | 2010-01-01 – 2010-12-31 | evidence 0001415889-12-000359 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).